A research request: I am a psychology student currently working on behalf of King’s with Professor Rona Moss-Morris and neurologist Dr Victoria Williams on a large scale project looking at fatigue in MS.
Research request from a psychology student Read More »
Source Multiple Sclerosis News Today: Inhibition of the neuroactive opioid growth factor (OGF) alters the blood levels of important pro- and anti-inflammatory proteins in mice with multiple sclerosis (MS)-like disease.
Low-dose Naltrexone Changes Levels of Inflammatory Proteins in MS, Study Shows Read More »
Opinion Health is currently conducting a study that involves patients with multiple sclerosis, and we would like to kindly ask for your support.
A £10 gesture of thanks offered to MS participants who complete survey Read More »
Source EurekAlert: Guardian molecule induced by testosterone reverses harmful immune response, eliminates disease symptoms in female mice.
Men hold secret to protect women from multiple sclerosis Read More »
Source MS Trust: NICE has recommended Extavia, but rejected Copaxone, Avonex, Betaferon, Plegridy and Rebif in its preliminary appraisal of MS drugs. The MS Trust has responded to NICE’s consultation in the strongest possible terms.
NICE proposes rejecting five drugs for relapsing MS – MS Trust responds Read More »
Source MS Society: Ocrelizumab has been approved as the first licensed treatment for some people with primary progressive MS in the UK.
Ocrelizumab licensed for people with early primary progressive MS in the UK Read More »
Source Radio Times: Documentary following leading lawyer Mark Lewis, the man who fought the News of the World in the phone hacking scandal, as he joins a clinical trial that might offer a breakthrough cure for multiple sclerosis. He learned he had the condition at the age of 25 but his high-profile battle with the
The Search for a Miracle Cure – Channel 4, 23rd November at 10pm Read More »
Source Multiple Sclerosis News Today: Multiple sclerosis (MS) patients being treated with dronabinol, a cannabinoid, do not show signs of drug abuse or dependency, leading researchers to conclude it has potential to be a long-term and safe treatment option for neuropathic pain.
Source Multiple Sclerosis News Today: Celgene released the results of two Phase 3 trials showing that patients with relapsing multiple sclerosis (MS) who were treated with ozanimod had lower relapse rates and fewer MRI brain lesions compared to those given a current first-line therapy, Avonex (interferon β-1a). These results will be used to support a request for ozanimod’s approval as an MS therapy
Ozanimod Superior to Avonex in Treating Relapsing MS in Phase 3 Trials, Celgene Reports Read More »
Source MS Society: There’s mounting evidence to show that cannabis could help pain and muscle spasms for people with MS. But with tonnes of information swirling around the internet, it’s hard to be sure what’s true and what’s not. We dived into the details to bust 5 common myths about cannabis and MS: 1. ‘Cannabis for
The MS Society explore 5 myths about cannabis and MS Read More »
